https://www.selleckchem.com/pr....oducts/guggulsterone
No significant change was seen in MV days, ICU length of stay, or self-extubation rates.Ovarian cancer is common gynaecological malignancy and a leading cause of death among women. Despite the advances in treatment strategies, majority of patients present with recurrence after first- or second-line treatment. Targeted therapy that has proven to be effective in other advanced or metastatic solid tumors have also demonstrated its efficacy in ovarian cancer. Recent studies have shown that the androgen receptor (AR) signalling is invo
Like
Comment
Share
